Details for New Drug Application (NDA): 218461
✉ Email this page to a colleague
The generic ingredient in FAMOTIDINE is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and eighty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.
Summary for 218461
Tradename: | FAMOTIDINE |
Applicant: | Graviti Pharms |
Ingredient: | famotidine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 218461
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Mar 14, 2024 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Mar 14, 2024 | TE: | RLD: | No |
Complete Access Available with Subscription